Patent · US Active

Small molecule antagonists of bacterial quorum-sensing receptors

US9084773B2 · kind B2 · utility

0Cited by
1References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 28, 2014
Grant dateJul 21, 2015
Priority date
Expiry dateMay 28, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/36
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A novel small molecule antagonizes two types of acyl homoserine lactone receptors: membrane-bound and cytoplasmic. A focused library of analogs and derivatives of the original antagonist was synthesized. Analog and derivative molecules harbor a range of activities. The novel small molecule and most potent antagonist protects the eukaryote Caenorhabditis elegans from quorum-sensing-mediated killing by the bacterial pathogen Chromobacterium violaceum. The saving of C. elegans demonstrates the use of these molecules as small molecule antimicrobials.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.